EcoDrugPlus

Coiled-Coil Domain Containing 6b

Ensembl ID : ENSEBUG00000015010
Gene Symbol: CCDC6B
1 Cross references
223 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSEBUG00000002230
Gene Symbol: CDK1
1 Cross references
246 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSEBUG00000007048
Gene Symbol: CDK2
1 Cross references
204 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSEBUG00000011609
Gene Symbol: CDK4
1 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 5

Ensembl ID : ENSEBUG00000006464
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSEBUG00000003070
Gene Symbol: CDK7
1 Cross references
219 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSEBUG00000010781
Gene Symbol: CDK9
1 Cross references
208 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSEBUG00000015562
Gene Symbol: CYSLTR1
1 Cross references
293 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSEBUG00000013465
Gene Symbol: DGAT1A
1 Cross references
265 Possible Orthologues:

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSEBUG00000015615
Gene Symbol: DPYDB
1 Cross references
231 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSEBUG00000003084
Gene Symbol: DRD1B
1 Cross references
312 Possible Orthologues:

Dopamine Receptor D7

Ensembl ID : ENSEBUG00000001269
Gene Symbol: DRD7
1 Cross references
387 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).